Nanologica AB (OSTO:NICA) OCF Margin %: -28.98% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:NICA Nanologica AB OSTO:NICA
45 GF Score
Price kr0.47
GF Value kr4.24
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Nanologica AB OCF Margin %?

Nanologica AB OSTO:NICA +5.10% 45 OCF Margin % is -28.98% as of Mar. 2026. GuruFocus rates OSTO:NICA with a GF Score™ of 45/100 and a GF Value™ of kr4.24 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 950 Biotechnology companies, Nanologica AB ranks worse than 51.79% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nanologica AB's Cash Flow from Operations for the three months ended in Mar. 2026 was kr-6.22 Mil. Nanologica AB's Revenue for the three months ended in Mar. 2026 was kr21.46 Mil. Therefore, Nanologica AB's OCF Margin % for the quarter that ended in Mar. 2026 was -28.98%.

As of today, Nanologica AB's current OCF Yield % is -17.65%.

The historical rank and industry rank for Nanologica AB's OCF Margin % or its related term are showing as below:

OSTO:NICA' s OCF Margin % Range Over the Past 10 Years
Min: -2907.97   Med: -457.68   Max: -105.9
Current: -84.57

During the past 12 years, the highest OCF Margin % of Nanologica AB was -105.90%. The lowest was -2907.97%. And the median was -457.68%.

OSTO:NICA's OCF Margin % is ranked worse than
51.79% of 950 companies
in the Biotechnology industry
Industry Median: -64.565 vs OSTO:NICA: -84.57

Nanologica AB OCF Margin % Related Terms

Nanologica AB OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nanologica AB's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanologica AB OCF Margin % Chart

Nanologica AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -360.02 -2,907.97 -2,484.27 -555.33 -188.54

Nanologica AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -178.53 -24.58 -375.73 -181.59 -28.98

OSTO:NICA vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Nanologica AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanologica AB OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanologica AB's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Nanologica AB's OCF Margin % falls into.


OSTO:NICA
45GF Score
Nanologica AB OSTO:NICA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanologica AB OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nanologica AB's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-39.832/21.127
=-188.54 %

Nanologica AB's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-6.217/21.456
=-28.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -28.98% mean?
Nanologica AB (OSTO:NICA) has a OCF Margin % of -28.98% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nanologica AB and its competitors. According to the industry distribution chart, Nanologica AB ranks #492 out of 950 companies in the Biotechnology industry, placing it in the top 51.8%.
Is Nanologica AB's OCF Margin % too high?
Nanologica AB's current OCF Margin % is -28.98%. Based on the distribution chart, Nanologica AB ranks #492 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nanologica AB has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nanologica AB's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nanologica AB ranks #492 out of 950 companies for OCF Margin %. This places Nanologica AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nanologica AB and its competitors. Nanologica AB's current OCF Margin % is -28.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanologica AB stock overvalued right now?
Based on GuruFocus' analysis, Nanologica AB (OSTO:NICA) is currently considered Possible Value Trap. The stock's GF Value™ is kr4.24, compared to a current price of kr0.47 — trading 88.8% below its estimated fair value. The current OCF Margin % is -28.98%. Nanologica AB's overall GF Score™ is 45/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Nanologica AB (OSTO:NICA), the current OCF Margin % is -28.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanologica AB (OSTO:NICA) Overvalued in 2026?

Based on GuruFocus' analysis, Nanologica AB stock appears to be undervalued. The current stock price of kr0.47 is trading 88.8% below its estimated GF Value™ of kr4.24. GuruFocus considers Nanologica AB to be Possible Value Trap.

Key valuation signals for OSTO:NICA:

  • OCF Margin %: -28.98%
  • GF Value™: kr4.24 vs. price of kr0.47 (88.8% below fair value)
  • GF Score™: 45/100 with 9 warning signs

No single metric tells the full story. See the OSTO:NICA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanologica AB Business Description

Other Exchanges 4YD:Germany
Address Forskargatan 20 G, Sodertalje, SWE, 151 36
Nanologica AB is a Swedish life science tools company that develops, manufactures, and sells key consumables to pharmaceutical manufacturers. Its products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, it can increase productivity and reduce costs for pharmaceutical manufacturers. The group operates in a world-wide niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company's mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments.
45GF Score

Get the complete analysis for OSTO:NICA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.47
Price
kr4.24
GF Value